AS-252424
CAS No. 900515-16-4
AS-252424( AS252424 | AS 252424 | AS-252424 )
Catalog No. M16475 CAS No. 900515-16-4
AS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 205 | In Stock |
|
| 50MG | 309 | In Stock |
|
| 100MG | 447 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAS-252424
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
-
DescriptionAS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
-
In VitroAS-252424 also inhibits PI3Kα, PI3Kβ and PI3Kδ with IC50s of 935±150 nM, 20 μM and 20 μM, respectively. AS-252424 inhibits MCP-1-mediated chemotaxis in wild-type primary monocytes in a concentration-dependent manner with an IC50 value of 52 μM, as well as in the monocytic cell line THP-1 with an IC50 value of 53 μM. In the human monocytic cell line THP-1, MCP-1 binding to the GPCR chemokine receptor CCR2, strongly induces phosphorylation of PKB/Akt, which is effectively inhibited by AS-252424 at IC50 values as low as 0.4 μM. In contrast, induction of PKB/Akt phosphorylation by colony stimulating factor (CSF-1), binding to the growth factor receptor c-fms, is only blocked by AS-252424 at IC50 values as high as 4.7 μM.
-
In VivoOral administration of AS-252424 in a mouse model of acute peritonitis leads to a significant reduction of leukocyte recruitment. To evaluate the efficacy of AS-252424 to block leukocyte migration in vivo, it is tested in a mouse model of thioglycollate-induced peritonitis. Oral administration of AS-252424 at 10 mg/kg results in moderate reduction of neutrophil recruitment (35%±14%), almost matching the result observed in PI3Kγ-deficient mice. Given the short oral half-life of AS-252424 (t1/2=1 h) and relative high clearance (2.25 L/kg per h), investigations at later time points (24-48 h) to assess macrophage and monoycyte recruitment are not undertaken. The modest pharmacokinetic properties do not appear to be caused by rapid oxidative metabolism (microsomal metabolism after 1 h: 16% (rat), 10% (human)).
-
SynonymsAS252424 | AS 252424 | AS-252424
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kγ| PI3Kα| Casein KiN/Ase 2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number900515-16-4
-
Formula Weight305.28
-
Molecular FormulaC??H?FNO?S
-
Purity>98% (HPLC)
-
SolubilityDMSO:30.5 mg/mL (100 mM)
-
SMILESO=C(NC/1=O)SC1=C/C2=CC=C(C3=CC=C(F)C=C3O)O2
-
Chemical Name(Z)-5-((5-(4-fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pomel V, et al. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem. 2006 Jun 29;49(13):3857-71.
molnova catalog
related products
-
GNE-490
GNE-490 is a potent, selective, orally available class I PI3K inhibitor.
-
SF-1126
SF-1126?is a pan PI3K/BRD4 inhibitor, RGDS-conjugated LY294002 prodrug that exhibits increased solubility and binds to specific integrins.
-
PI3Kδ-IN-3
PI3Kδ-IN-3 (TC KHNS 11) is a PI3Kδ inhibitor with an IC50 value of 9 nM.PI3Kδ-IN-3 has a favorable pharmacokinetic profile and inhibits B cell function.
Cart
sales@molnova.com